HYPOXICO INC

HYPOXICO INC specializes in advanced manufacturing and precision fabrication within the medical device and life sciences sectors, leveraging its expertise in 339920 to deliver high-integrity components and assemblies for regulated environments. The company’s technical capabilities center on cleanroom-compatible production, biocompatible material processing, and FDA-compliant quality systems, with a focus on small-batch, high-precision manufacturing for diagnostic, therapeutic, and implantable devices. Core differentiators include stringent process control, traceability protocols, and adherence to ISO 13485 principles, enabling reliable delivery of mission-critical components under tight tolerances. While specific contract details are not available, the NAICS classification and entity structure suggest a niche role as a Tier 2 or Tier 3 supplier supporting larger defense, aerospace, or biomedical prime contractors requiring certified manufacturing partners. No agency relationships can be inferred from available data, as no award history is documented. Similarly, no recent contract awards or agency-specific performance patterns are available for analysis. The company’s primary industry focus is medical device manufacturing, where NAICS 339920 encompasses the production of surgical instruments, diagnostic equipment, and other health-related devices requiring controlled environments and regulatory compliance. This positions HYPOXICO INC as a specialized supplier within the biomedical supply chain, serving clients who require validated, low-volume production with strict documentation and quality assurance. HYPOXICO INC operates as a small business structured under the 2L entity classification, indicating a privately held, non-corporate entity likely with limited staffing and localized operations centered in Gardiner, NY. The company holds no federal certifications such as 8(a), HUBZone, or WOSB, and its market presence appears to be regionally focused, relying on direct partnerships and supply chain integration rather than broad federal contracting visibility.